- Home
- RDN vs GH Comparison
RDN vs GH Comparison
Compare RDN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDN
- GH
- Stock Information
- Founded
- RDN 1977
- GH 2011
- Country
- RDN United States
- GH United States
- Employees
- RDN N/A
- GH N/A
- Industry
- RDN Property-Casualty Insurers
- GH Medical Specialities
- Sector
- RDN Finance
- GH Health Care
- Exchange
- RDN Nasdaq
- GH Nasdaq
- Market Cap
- RDN 5.3B
- GH 4.3B
- IPO Year
- RDN 1992
- GH 2018
- Fundamental
- Price
- RDN $31.71
- GH $34.02
- Analyst Decision
- RDN Buy
- GH Strong Buy
- Analyst Count
- RDN 5
- GH 15
- Target Price
- RDN $36.10
- GH $39.93
- AVG Volume (30 Days)
- RDN 869.8K
- GH 1.6M
- Earning Date
- RDN 02-05-2025
- GH 11-06-2024
- Dividend Yield
- RDN 3.03%
- GH N/A
- EPS Growth
- RDN N/A
- GH N/A
- EPS
- RDN 3.86
- GH N/A
- Revenue
- RDN $1,303,066,000.00
- GH $692,256,000.00
- Revenue This Year
- RDN N/A
- GH $32.23
- Revenue Next Year
- RDN $3.15
- GH $16.90
- P/E Ratio
- RDN $8.40
- GH N/A
- Revenue Growth
- RDN 6.23
- GH 29.20
- 52 Week Low
- RDN $26.11
- GH $15.81
- 52 Week High
- RDN $37.86
- GH $38.53
- Technical
- Relative Strength Index (RSI)
- RDN 30.16
- GH 58.28
- Support Level
- RDN $33.31
- GH $34.20
- Resistance Level
- RDN $34.08
- GH $36.24
- Average True Range (ATR)
- RDN 0.70
- GH 1.40
- MACD
- RDN -0.28
- GH -0.54
- Stochastic Oscillator
- RDN 1.82
- GH 12.70
About RDN Radian Group Inc.
Radian Group Inc provides mortgage insurance and services to the real estate and mortgage finance industries. Radian's mortgage insurance provides coverage to lending institutions throughout the United States. Its services include analytics and consulting for buyers and sellers of, and investors in, mortgage- and real estate-related loans and securities and other asset-backed securities. Insurance premiums account for more than three fourths of the company's revenue. Services revenue and investment income are the other principal sources of revenue. It operates in two segments: Mortgage and homegenius. The Mortgage segment earns the majority of revenue.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.